Physician

Tyler Lee Davis, M.D.

According to 2025 Medicare claims, Tyler Davis, M.D. (NPI: 1679734891) practices hematology/oncology in the Riverside-San Bernardino-Ontario, CA market, with the plurality of this provider's patient population coming from Riverside, CA. This provider's primary affiliated billing organization is DESERT HEMATOLOGY-ONCOLOGY MEDICAL GROUP INC (NPI: 1427069368; TIN: 953300691) and primary practice location at 92270-1713.

Davis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 505 traditional Medicare patients, billed 169,059 HCPCS/CPT codes, and received $1,738,117 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 480 prescription claims across 97 beneficiaries totaling $1,265,506 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2023 DME data shows 29 claims. Open Payments data shows 160 records totaling $3,617. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$869K$1.7M2022 Medicare payment: $497,792 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,130,526 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,738,117 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202226936,515$497,792
2023459116,299$1,130,526
2024505169,059$1,738,117

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$633K$1.3M2022 Drug cost: $23,322 (USD; Tot_Drug_Cst)2023 Drug cost: $512,601 (USD; Tot_Drug_Cst)2024 Drug cost: $1,265,506 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20222545$23,322
202365231$512,601
202497480$1,265,506

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.9K$5.7K2023 Medicare payment: $5,723 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R29$5,723
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more232575$99
96372Injection of drug or substance under skin or into muscle175364$12
80053Blood test, comprehensive group of blood chemicals182463$10
36415Insertion of needle into vein for collection of blood sample269592$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count289820$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JakafiRuxolitinib Phosphate12360$211,213
EliquisApixaban902,828$54,356
XareltoRivaroxaban221,020$18,965
AnastrozoleAnastrozole251,620$743
DexamethasoneDexamethasone31930$510

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.160$3,617Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Tyler Lee Davis, M.D.?

Tedicare shows public-source Medicare data for Tyler Lee Davis, M.D. (NPI 1679734891), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tyler Lee Davis, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tyler Lee Davis, M.D.?

Tyler Lee Davis, M.D. is linked to DESERT HEMATOLOGY-ONCOLOGY MEDICAL GROUP INC (billing NPI 1427069368) in the available physician profile data.

Does Tyler Lee Davis, M.D. have Open Payments data?

Tyler Lee Davis, M.D. has 160 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.